ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 227.40
-0.80 (-0.35%)
Oct 9, 2026, 4:59 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 50.46 billion as of October 9, 2026. It is the 2,682nd most valuable company in the world and the 16th biggest in Denmark. Its market cap has increased by 5.61% in one year.
Market Cap
50.46B
Enterprise Value
49.14B
Revenue
6.83B
Global Rank
Country Rank
#16 Denmark
PE Ratio
37.29
ChartMarket Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 50.46B, an increase of 630.39%. That is a compound annual growth rate of 10.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 50.46B | -0.21% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Genmab | 146.10B |
| Coloplast | 98.15B |
| Demant | 71.96B |
| H. Lundbeck | 45.13B |
| Ambu A/S | 19.02B |
| Bavarian Nordic | 17.93B |
| Zealand Pharma | 16.21B |